(2011) Synthesis of Unnatural Enone-Containing Α- Amino Acids: Precursors to Chiral N-Heterocycles

Total Page:16

File Type:pdf, Size:1020Kb

(2011) Synthesis of Unnatural Enone-Containing Α- Amino Acids: Precursors to Chiral N-Heterocycles Fowler, Lindsay S.(2011) Synthesis of unnatural enone-containing α- amino acids: Precursors to chiral N-heterocycles. PhD thesis. http://theses.gla.ac.uk/2524/ Copyright and moral rights for this thesis are retained by the author A copy can be downloaded for personal non-commercial research or study, without prior permission or charge This thesis cannot be reproduced or quoted extensively from without first obtaining permission in writing from the Author The content must not be changed in any way or sold commercially in any format or medium without the formal permission of the Author When referring to this work, full bibliographic details including the author, title, awarding institution and date of the thesis must be given Glasgow Theses Service http://theses.gla.ac.uk/ [email protected] Synthesis of Unnatural Enone-Containing α-Amino Acids: Precursors to Chiral N-Heterocycles Lindsay S. Fowler, M. Sci. A thesis submitted in part fulfilment of the requirements for the degree of Doctor of Philosophy. School of Chemistry College of Science and Engineering University of Glasgow February 2011 P a g e | i Abstract A fast and efficient synthetic route was developed for the synthesis of a novel class of enone- containing α-amino acid. An amino acid-derived β-ketophosphonate ester was subjected to Horner-Wadsworth-Emmons conditions using a variety of aldehydes to produce a diverse library of α,β-unsaturated amino acids. E-Configured enone-containing amino acids were also deprotected using a two-stage approach to give the parent α-amino acids. A minor modification to the route enabled the synthesis of Z-configured enones via the Still-Gennari reaction. A small library of Z-enones was produced using various aldehydes. Enone-functionalised α-amino acids were employed as substrates for an intramolecular cyclisation reaction to generate 6-substituted-4-oxopipecolic acids. A diastereoselective one-pot reductive amination/cyclisation strategy was developed to gain access to the anti-diastereomer of the chiral N-heterocycles. A small selection of 6-substituted-4-oxopipecolic acids was synthesised. 6-Substituted-4-oxopipecolic acids were also reduced diastereoselectively to generate 4- hydroxypipecolic acid analogues. P a g e | ii Contents Abstract ......................................................................................................................................... i Contents ........................................................................................................................................ii Acknowledgement .........................................................................................................................v Author’s Declaration ..................................................................................................................... vi Abbreviations............................................................................................................................... vii 1 Saturated 6-Membered N-Heterocycles ................................................................................ 1 1.1 Introduction .................................................................................................................. 1 1.2 Piperidine ...................................................................................................................... 2 1.2.1 Piperidine Synthesis ............................................................................................... 6 1.2.1.1 Reduction of Pyridine ......................................................................................... 6 1.2.1.2 Heterocycle Construction ................................................................................... 8 1.2.1.3 Cycloaddition ................................................................................................... 12 1.2.1.4 Ring Expansion / Rearrangement...................................................................... 13 1.3 Pipecolic Acid............................................................................................................... 15 1.3.1 4-Oxopipecolic Acid Synthesis .............................................................................. 22 1.3.1.1 Heterocycle Construction ................................................................................. 22 1.3.1.2 Cycloaddition ................................................................................................... 31 1.3.2 4-Hydroxypipecolic Acid Synthesis........................................................................ 38 1.3.2.1 Heterocycle Construction ................................................................................. 38 1.3.2.2 Cycloaddition ................................................................................................... 47 1.3.2.3 Ring Expansion / Rearrangement...................................................................... 52 1.4 Summary ..................................................................................................................... 54 1.5 Proposed Methodology to Synthesise 4-Oxygenated Pipecolic Acid Derivatives ........... 55 2 Novel Enone-Containing α-Amino Acids............................................................................... 57 2.1 Introduction ................................................................................................................ 57 P a g e | iii 2.2 Previous Syntheses of Enone-Containing α-Amino Acids .............................................. 57 2.3 Potential of Novel Enone-Containing α-Amino Acids .................................................... 61 2.4 Synthesis of Novel Enone-Containing α-Amino Acids ................................................... 62 2.4.1 E-Configured Enone-Functionalised α-Amino Acids .............................................. 62 2.4.2 Z-Configured Enone-Functionalised α-Amino Acids .............................................. 67 2.5 Further Elaboration of Novel Enone-Functionalised α-Amino Acids .............................. 70 2.6 Deprotection to Parent α-Amino Acids......................................................................... 72 2.6.1 Deprotection of E-Configured Enones .................................................................. 73 2.6.2 Deprotection of Z-Configured Enones .................................................................. 76 2.7 Stereochemical Evaluation ........................................................................................... 78 2.8 Application of Enone-Functionalised α-Amino Acids .................................................... 79 2.8.1 Fluorescent Labelling ........................................................................................... 80 2.8.2 Synthesis of a Novel α-Amino Acid Fluorophore ................................................... 80 2.9 Summary ..................................................................................................................... 83 3 Chiral 6-Substituted-4-Oxygenated Pipecolic Acid Derivatives ............................................. 84 3.1 Introduction ................................................................................................................ 84 3.2 Synthesis of 4-Oxopipecolic Acid Derivatives via an Intramolecular Conjugate Addition 85 3.2.1 Model Substrate 1 – Phenyl Derivative ................................................................. 86 3.2.2 Model Substrate 2 – Phenethyl derivative ............................................................ 88 3.3 One-Pot Reductive Amination/Intramolecular Cyclisation for the Synthesis of 4- Oxopipecolic Acid Derivatives .................................................................................................. 89 3.3.1 Rationale for the Observed Stereochemical Outcome of the Intramolecular Cyclisation ........................................................................................................................... 95 3.4 Reduction of 4-Oxo- to 4-Hydroxypipecolic Acid Derivatives ........................................ 97 3.4.1 Rationale for the Observed Stereochemical Outcome of the Reduction................ 99 3.4.2 Relative Stereochemistry ................................................................................... 102 3.5 Deprotection of 4-Hydroxypipecolic Acid ................................................................... 105 3.5.1 X-Ray Crystal Structure of 6-Methyl-4-Hydroxypipecolic Acid ............................. 106 3.6 Alternative Approach to 4-Oxopipecolic Acid Derivatives ........................................... 107 3.7 Future Work .............................................................................................................. 111 3.8 Summary ................................................................................................................... 113 4 Conclusions ....................................................................................................................... 115 5 Experimental ..................................................................................................................... 117 5.1 General Considerations .............................................................................................. 117 5.2 General Experimental ................................................................................................ 117 P a g e | iv 5.3 Experimental Procedures ........................................................................................... 120 6 References .......................................................................................................................
Recommended publications
  • Enzymatic Synthesis of L-Pipecolic Acid by \Delta
    Biosci. Biotechnol. Biochem., 70 (9), 2296–2298, 2006 Note Enzymatic Synthesis of L-Pipecolic Acid by Á1-Piperideine-2-carboxylate Reductase from Pseudomonas putida Hisashi MURAMATSU,1;*,** Hisaaki MIHARA,1;* Mari YASUDA,2 y Makoto UEDA,2 Tatsuo KURIHARA,1 and Nobuyoshi ESAKI1; 1Institute for Chemical Research, Kyoto University, Uji, Kyoto 611-0011, Japan 2Yokohama Research Center, Mitsubishi Chemical Corporation, Yokohama 227-8502, Japan Received March 9, 2006; Accepted April 30, 2006; Online Publication, September 7, 2006 [doi:10.1271/bbb.60125] L-Pipecolic acid is a chiral pharmaceutical intermedi- Á1-piperideine-2-carboxylate (Pip2C) reductase from ate. An enzymatic system for the synthesis of L-pipecolic Pseudomonas putida.17) The enzyme, which belongs acid from L-lysine by commercial L-lysine -oxidase to a new NAD(P)H-dependent oxidoreductase fami- from Trichoderma viride and an extract of recombinant ly,18,19) catalyzes the reduction of Pip2C to L-pipecolic Escherichia coli cells coexpressing Á1-piperideine-2- acid and is involved in D-lysine catabolism.17) In this carboxylate reductase from Pseudomonas putida and paper, we describe the production of L-pipecolic acid glucose dehydrogenase from Bacillus subtilis is describ- by an enzyme-coupled system consisting of Pip2C ed. A laboratory-scale process provided 27 g/l of L- reductase, glucose dehydrogenase (GDH) from Bacillus pipecolic acid in 99.7% e.e. subtilis,20) and commercial L-lysine -oxidase from Trichoderma viride (Yamasa, Hiroshima, Japan) Key words: Á1-piperideine-2-carboxylate
    [Show full text]
  • Uncovering Mechanisms of Global Ocean Change Effects on the Dungeness Crab (Cancer Magister) Through Metabolomics Analysis
    www.nature.com/scientificreports OPEN Uncovering mechanisms of global ocean change efects on the Dungeness crab (Cancer magister) Received: 26 October 2018 Accepted: 4 July 2019 through metabolomics analysis Published: xx xx xxxx Shelly A. Trigg 1,2,5, Paul McElhany3, Michael Maher3, Danielle Perez3, D. Shallin Busch3,4 & Krista M. Nichols3 The Dungeness crab is an economically and ecologically important species distributed along the North American Pacifc coast. To predict how Dungeness crab may physiologically respond to future global ocean change on a molecular level, we performed untargeted metabolomic approaches on individual Dungeness crab juveniles reared in treatments that mimicked current and projected future pH and dissolved oxygen conditions. We found 94 metabolites and 127 lipids responded in a condition-specifc manner, with a greater number of known compounds more strongly responding to low oxygen than low pH exposure. Pathway analysis of these compounds revealed that juveniles may respond to low oxygen through evolutionarily conserved processes including downregulating glutathione biosynthesis and upregulating glycogen storage, and may respond to low pH by increasing ATP production. Most interestingly, we found that the response of juveniles to combined low pH and low oxygen exposure was most similar to the low oxygen exposure response, indicating low oxygen may drive the physiology of juvenile crabs more than pH. Our study elucidates metabolic dynamics that expand our overall understanding of how the species might respond to future ocean conditions and provides a comprehensive dataset that could be used in future ocean acidifcation response studies. Te continued increase in anthropogenic carbon dioxide emissions is leading to ocean acidifcation, with the ocean absorbing an average of 25% of human-caused emissions annually1.
    [Show full text]
  • The Genome of Undifilum Oxytropis Provides Insights Into Swainsonine
    www.nature.com/scientificreports OPEN The Genome of Undifilum oxytropis Provides Insights into Swainsonine Biosynthesis and Locoism Received: 08 April 2016 Hao Lu, Haiyun Quan, Zhenhui Ren, Shuai Wang, Ruixu Xue & Baoyu Zhao Accepted: 08 July 2016 Undifilum oxytropis is a fungal endophyte of locoweeds. It produces swainsonine, which is the principal Published: 01 August 2016 toxic ingredient of locoweeds. However, the genes, pathways and mechanisms of swainsonine biosynthesis are not known. In this study, the genome of U. oxytropis was firstly sequenced and assembled into a 70.05 megabases (Mb) draft genome, which encoded 11,057 protein-coding genes, and 54% of them were similar to current publicly available sequences. U. oxytropis genes were annotated and 164 putative genes were annotated into enzymes, such as Saccharopine dehydrogenase, Saccharopine oxidase, and Pyrroline-5-carboxylate reductase, hypothesized to be involved in the biosynthesis pathway of swainsonine. The genome sequence and gene annotation of U. oxytropis will provide new insights into functional analyses. The characterization of genes in swainsonine biosynthesis will greatly facilitate locoweed poisoning research and help direct locoism management. Locoweeds are poisonous legumes that belong to the genera Oxytropis and Astragalus. After ingesting these toxic plants, livestock can develop diseases characterised by chronic dysfunction of the nervous system1–3. In China, the morbidity and death rate of livestock caused by locoweed poisoning have increased annually and led to large economic losses in the western rangelands of China in the last fifty years4. The principal toxic ingredient of locoweeds is the indolizidine alkaloid swainsonine (SW)5–10. SW pri- marily inhibits the activities of Golgi apparatus α - mannosidase II (MAN2A1) and lysosome α - mannosi- dase (MAN2B1)11–13.
    [Show full text]
  • Expanding Metabolic Pathway for De Novo Biosynthesis of the Chiral Pharmaceutical Intermediate L-Pipecolic Acid in Escherichia C
    Ying et al. Microb Cell Fact (2017) 16:52 DOI 10.1186/s12934-017-0666-0 Microbial Cell Factories RESEARCH Open Access Expanding metabolic pathway for de novo biosynthesis of the chiral pharmaceutical intermediate L‑pipecolic acid in Escherichia coli Hanxiao Ying1,2†, Sha Tao1,2†, Jing Wang1,2, Weichao Ma1,2, Kequan Chen1,2*, Xin Wang1,2 and Pingkai Ouyang1,2 Abstract Background: The six-carbon circular non-proteinogenic compound L-pipecolic acid is an important chiral drug inter- mediate with many applications in the pharmaceutical industry. In the present study, we developed a metabolically engineered strain of Escherichia coli for the overproduction of L-pipecolic acid from glucose. Results: The metabolic pathway from L-lysine to L-pipecolic acid was constructed initially by introducing lysine cyclodeaminase (LCD). Next, L-lysine metabolic flux from glucose was amplified by the plasmid-based overexpression of dapA, lysC, and lysA under the control of the strong trc promoter to increase the biosynthetic pool of the precur- sor L-lysine. Additionally, since the catalytic efficiency of the key enzyme LCD is limited by the cofactor NAD+, the intracellular pyridine nucleotide concentration was rebalanced by expressing the pntAB gene encoding the tran- shydrogenase, which elevated the proportion of LCD with bound NAD+ and enhanced L-pipecolic acid production 2 significantly. Further, optimization of Fe + and surfactant in the fermentation process resulted in 5.33 g/L L-pipecolic acid, with a yield of 0.13 g/g of glucose via fed-batch cultivation. Conclusions: We expanded the metabolic pathway for the synthesis of the chiral pharmaceutical intermediate L-pipecolic acid in E.
    [Show full text]